Tag: PrEP

5 ways that PrEP highlights gender inequities in HIV

One of the most memorable moments in my 20 years working in the HIV field happened in a standing-room-only meeting hall in Vienna at the International AIDS Conference in 2010. This was the moment that the clinical trial CAPRISA 004 announced proof-of-concept for prevention of HIV among women using a vaginal microbicide (1% tenofivir gel). The entire room broke out in a standing ovation and tears of joy. Finally! A prevention tool that could allow a woman to protect herself in sexual encounters, regardless of the desires and wishes of her sexual partner.

Read more

IAS 2015: A watershed moment in the HIV response

Vancouver is in the limelight again. This year’s International AIDS Society (IAS) Conference may have marked a watershed moment in our HIV response, with some similarity to the 1996 Vancouver AIDS conference when highly active antiretroviral therapy (HAART) hit the world stage.

Read more

“Unprotected” or “condomless”: Upgrading our HIV terminology

What do you call sex without a condom? Unprotected? Only a few years ago, you might have been correct. But a growing consensus of HIV prevention experts is shifting away from this terminology to something more accurate and more simple: sex without a condom, or condomless sex. Why? Our understanding of HIV transmission and prevention has changed dramatically in the past decade, and with it have come new words and terms. Post- and pre-exposure prophylaxis (PEP and PrEP). Undetectable viral load. Treatment as prevention.

Read more

There is a drug to prevent HIV. Why isn’t it approved in Canada?

Recent developments in prevention are pointing to worrying gaps in the community-based approach to HIV prevention in Canada. Perhaps we have been used to having only a single prevention technology on our books for so long – think condoms – that our ducks are not always in a row when new ones like PrEP come along. Thus potholes in our response become apparent – and none leap in to fix them. After a series of somewhat inconclusive PrEP trials, whose results were marred by adherence issues, the results of more stringent trials like the PROUD and IPERGAY studies are in,...

Read more